Skip to content

Regulating the immunity (Immunomodulatory) in children with wheeze by using homeopathic drug arsenicum album

The immunomodulatory effect of homoeopathic drug arsenicum album in children with wheeze

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041250
Enrollment
102
Registered
2022-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: ARSENICUM ALBUM: IMMUNOMODULATORY EFFECT OF HOMOEOPATHIC DRUG ARSENICUM ALBUM IN CHILDREN WITH WHEEZE - Dose _ Fifity Millesimal. two doses morning and night, oral route for 6 months o

Sponsors

DrSanthosh Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children between the age of 2 to 5 years suffering from repeated attacks of cold and cough with wheeze of unspecified ethology for more than 3 times in a year with the gap of less than 2 months will be selected for the study.

Exclusion criteria

Exclusion criteria: 1.Children should not be under Homoeopathic treatment for the given condition for at least three months. (wash out period) 2.Presence of obstructive lung disease 3.Other Cardiovascular disease 4.Known chronic infections 5.Congenital disorders 6.Known malignancy 7.Inflammatory connective tissue 8.Should not have received steroid for any clinical conditions for the last three months.

Design outcomes

Primary

MeasureTime frame
Improvement in terms of reduction in the frequency , duration and severity of each episode in the intervention arm compared to the placebo arm. Timepoint: baseline - Improvement in terms of reduction in the frequency , duration and severity of each episode in the intervention arm compared to the placebo arm assessment repeated at the 3rd and 6th month

Secondary

MeasureTime frame
Improvement in the Quality-of-Life Score in the intervention arm and placebo arm compared to the base line. â?¢ Reduction in the investigational parameters in the intervention arm compared to the placebo arm both at baseline and end of the study. Timepoint: end of 3rd month, 6th month, 9th month

Countries

India

Contacts

Public ContactDrCKMohan

sarada krishna Homoeoapthic Medical college

college@skhmc.org04651279448

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026